Medijski sadržaj
- Tweetovi
- Tweetovi i odgovori
- Medijski sadržaj, trenutna stranica.
-
For his “Make It Personal Day,” Nate Rosenthal volunteered w/
@SVdP_GA helping with a bicycle donation drive for foster children in Atlanta. We encourage our employees to take a "Make It Personal Day,” or time off to do something personal to them. http://bit.ly/2VucRA8 pic.twitter.com/95Qvxqoc1f
-
Hear how 3-year-old Nash’s parents made it their mission to
#smashSMARD after learning their child was diagnosed with spinal muscular atrophy with respiratory distress type 1 (SMARD1).#RAREis@smashSMARD.pic.twitter.com/lp6EKlOjH1 -
#RAREis Lynzi Russell, who was diagnosed with a urea cycle disorder (UCD) when she was 13 years old. Read as Lynzi explains how her life changed after fully embracing her#raredisease: http://bit.ly/2GF5fkk .pic.twitter.com/m5tqIWy2cy
-
We’ve received many questions about our new FDA-approved medicine for Thyroid Eye Disease. For more information, call 1-833-483-7399 (Mon–Fri 8 a.m.–8 p.m. EST) to speak to a Horizon Nurse Advocate. Also, check out our FAQ: http://bit.ly/2NLLKuq .pic.twitter.com/PPvyEnw2pw
-
Watch as Candis Thacker, territory manager, shares how going through six major surgeries in her first seven months as a Horizon employee changed the way she views her job. http://bit.ly/2VucRA8 pic.twitter.com/HEnpsEa7de
-
We were thrilled to host our second
@UNfoundation@GirlUp#STEM for Social Good Camp at our South San Francisco office. This program provides girls the opportunity to develop their leadership abilities and grow as changemakers.pic.twitter.com/xBdAutPE35
-
We’re thrilled to announce the significant expansion and relocation of our U.S. operations to a three-building, 70 acre campus in Deerfield, Ill., outside of Chicago. Learn more: http://bit.ly/2GrMSPQ .
$HZNPpic.twitter.com/Wtalu0TYEa
-
Last year, 30+ Horizon employees were matched to boards or committees of nonprofit organizations through our Boards+ program. Join a team that values your growth. http://bit.ly/2VucRA8 pic.twitter.com/TZdUwwQDPR
-
We hosted a panel discussion w/
@1776PHL on innovative approaches to addressing the challenges and barriers to research & drug development in#rarediseases. A big thank you to our panelists Jennifer Farmer, MS, CGC, Stephanie Fischer & Horizon’s Saba Sile, M.D.pic.twitter.com/7tslDS9AgN
-
We’ve received many Qs from the community about our new FDA approved medicine for Thyroid Eye Disease, that is approved for use throughout the U.S. For answers to frequently asked Qs & contact info to connect with a member of the Horizon team, click here: http://bit.ly/2NLLKuq pic.twitter.com/QM9ZeS5qML
Prikaži ovu nit -
On the heels of our recent FDA approval, today The New England Journal of Medicine published comprehensive data from our Phase 3 clinical trial (OPTIC) for Thyroid Eye Disease. Learn more: http://bit.ly/30SD6zO .
#ThyroidEyeDisease#rarediseasepic.twitter.com/CX9p3QqjM1
-
BREAKING NEWS: The FDA approved our medicine for the treatment of Thyroid Eye Disease (TED) yesterday. Learn more: http://bit.ly/30Hw1Sj .
#ThyroidEyeDisease#rarediseasepic.twitter.com/tzcIu6sDZS -
BREAKING NEWS: Today the FDA approved our medicine for the treatment of Thyroid Eye Disease (TED). Learn more: http://bit.ly/30Hw1Sj .
#ThyroidEyeDisease#rarediseasepic.twitter.com/pk1ZvDUtA5Prikaži ovu nit -
This weekend, Carlos Blocker, specialty account manager, and his family traveled to Washington, D.C. to visit the Martin Luther King Jr. Memorial to honor Dr. King’s legacy of equality and hope.
#MLKDay
pic.twitter.com/D4O34JRXdk
-
For their “Make It Personal Day,” an additional day off to do something meaningful & personal to each employee, our business development team volunteered together at
@fmsc_org packing meals for children in need. http://bit.ly/2VoAIk0 pic.twitter.com/5Kox9oBAS4
-
Happening now:
@HorizonCEOTW is presenting at#JPM20, available via webcast. Watch: http://bit.ly/2N9hpFN .$HZNPpic.twitter.com/8iiuOukiDd
-
At
#JPM20? Be sure to stop by@GlobalGenes’#RAREintheSquare event today. Join us to discuss how to advance#raredisease research and treatment.#CareAboutRarepic.twitter.com/FA5Lt5grRp
-
Today at 5 p.m. PST,
@HorizonCEOTW will present at#JPM20. Watch: http://bit.ly/2N9hpFN .$HZNPpic.twitter.com/AFjNJOZMAJ
-
Here for
#JPMHC20? With our South San Francisco manufacturing and research and development facility now open on Highway 101, we look forward to building new partnerships with the life sciences community in California.#JPM20pic.twitter.com/RzUhz2MYdH
-
MIRROR open-label study data indicates a significant improvement in response rate, which may allow more people living with uncontrolled gout to benefit from a full course of therapy. Topline data shows 79% of patients achieved a complete response. http://bit.ly/36OUFmz pic.twitter.com/vVB1JaBZcr
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.